Actions
  • shareshare
  • link
  • cite
  • add
add
auto_awesome_motion View all 4 versions
Publication . Article . 2015

Spontaneous bacterial peritonitis due to methicillin-resistant Staphylococcus aureus in a patient with cirrhosis: the potential role for daptomycin and review of the literature

Marco Falcone; Alessandro Russo; Giovanni Pacini; Manuela Merli; Mario Venditti;
Open Access
English
Published: 01 Sep 2015 Journal: Infectious Disease Reports, volume 7, issue 3 (issn: 2036-7430, eissn: 2036-7449, Copyright policy )
Publisher: MDPI AG
Abstract

Gram-positive cocci are emerging causes of spontaneous bacterial peritonitis (SBP), especially in patients with healthcare-associated infections. We report the case of a 68-year-old man with hepatitis C virus and alcohol-related cirrhosis who developed SBP due to methicillin-resistant Staphylococcus aureus treated with daptomycin. We discuss the potential role of daptomycin in this setting with a review of the literature about the use of daptomycin in primary or secondary bacterial peritonitis.

Subjects by Vocabulary

Library of Congress Subject Headings: lcsh:Other systems of medicine lcsh:RZ201-999

Medical Subject Headings: bacterial infections and mycoses biochemical phenomena, metabolism, and nutrition lipids (amino acids, peptides, and proteins) polycyclic compounds

Microsoft Academic Graph classification: In patient Methicillin-resistant Staphylococcus aureus medicine.disease_cause medicine Cirrhosis medicine.disease Bacterial Peritonitis Daptomycin medicine.drug Microbiology Spontaneous bacterial peritonitis Staphylococcus aureus business.industry business Hepatitis C virus

Subjects

Daptomycin, cirrhosis, methicillin-resistant Staphylococcus aureus, spontaneous bacterial peritonitis, Case Report, methicillinresistant Staphylococcus aureus, Infectious Diseases

Related Organizations
18 references, page 1 of 2

1.de Mattos AA Costabeber AM Lionço LC Tovo CV Multi-resistant bacteria in spontaneous bacterial peritonitis: A new step in management?World J Gastroenterol 2014;20:14079-86.25339797 [OpenAIRE] [PubMed]

2.Alexopoulou A Papadopoulos N Eliopoulos DG Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int 2013;33:975-81.23522099 [PubMed]

3.Campillo B Richardet JP Kheo T Dupeyron C Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 2002;35:1-10.12060868 [PubMed]

4.Merli M Lucidi C Giannelli V Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010;8:979-85.20621200 [PubMed]

5.van Hal SJ Lodise TP Paterson DL The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012;54:755-71.22302374 [PubMed]

6.Mortin LI Li T Van Praagh AD Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria. Antimicrob Agents Chemother 2007;51:1787-94.17307984 [OpenAIRE] [PubMed]

7.Khadzhynov D Joukhadar C Peters H Plasma and peritoneal dialysate levels during da ptomycin therapy for peritonitis. Am J Kidney Dis 2009;53:911-2.19393474 [PubMed]

8.Tascini C Di Paolo A Polillo M Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin. Antimicrob Agents Chemother 2011;55:2458-9.21343441 [OpenAIRE] [PubMed]

9.Piano S Fasolato S Salinas F The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized controlled clinical trial. Hepatology 2015 Jun 18 [Epub ahead of print]

10.Burklein D Heyn J Kirchhoff C Analysis of pla sma and peritoneal fluid concentrations of daptomycin in a patient with Enterococcus faecium peritonitis. Int J Antimicrob Agents 2008;32:369-71.18701260 [PubMed]

Related to Research communities
Heritage Science
Download fromView all 4 sources
lock_open
Infectious Disease Reports
Article
License: cc-by
Providers: UnpayWall
moresidebar